203 related articles for article (PubMed ID: 28459195)
21. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
[TBL] [Abstract][Full Text] [Related]
22. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.
Lu X; Jiang L; Zhang L; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Gao J; Su X; Yan F
Neoplasia; 2019 Jun; 21(6):591-601. PubMed ID: 31055200
[TBL] [Abstract][Full Text] [Related]
23. Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
Carestiato FN; Amaro-Filho SM; Moreira MAM; Cavalcanti SMB
Mem Inst Oswaldo Cruz; 2018 Dec; 114():e180456. PubMed ID: 30569945
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer subtypes harbouring integrated and/or episomal HPV16 portray distinct molecular phenotypes based on transcriptome profiling of mRNAs and miRNAs.
Mandal P; Saha SS; Sen S; Bhattacharya A; Bhattacharya NP; Bucha S; Sinha M; Chowdhury RR; Mondal NR; Chakravarty B; Chatterjee T; Roy S; Chattapadhyay A; Sengupta S
Cell Death Discov; 2019; 5():81. PubMed ID: 30937183
[TBL] [Abstract][Full Text] [Related]
25. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
Wang JT; Ding L; Gao ES; Cheng YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
[TBL] [Abstract][Full Text] [Related]
26. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
27. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia.
Ding DC; Chiang MH; Lai HC; Hsiung CA; Hsieh CY; Chu TY
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):215-20. PubMed ID: 19819061
[TBL] [Abstract][Full Text] [Related]
28. Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancer pathogenesis.
Sharma Saha S; Roy Chowdhury R; Mondal NR; Chakravarty B; Chatterjee T; Roy S; Sengupta S
Cell Oncol (Dordr); 2016 Dec; 39(6):559-572. PubMed ID: 27683269
[TBL] [Abstract][Full Text] [Related]
29. 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.
Morel A; Baguet A; Perrard J; Demeret C; Jacquin E; Guenat D; Mougin C; Prétet JL
Oncotarget; 2017 Jul; 8(28):46163-46176. PubMed ID: 28521287
[TBL] [Abstract][Full Text] [Related]
30. Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state.
Hanning JE; Saini HK; Murray MJ; Caffarel MM; van Dongen S; Ward D; Barker EM; Scarpini CG; Groves IJ; Stanley MA; Enright AJ; Pett MR; Coleman N
J Pathol; 2013 Nov; 231(3):354-66. PubMed ID: 23913724
[TBL] [Abstract][Full Text] [Related]
31. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2.
Bhattacharjee B; Sengupta S
Virology; 2006 Oct; 354(2):280-5. PubMed ID: 16905170
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.
Lai ZZ; Ni-Zhang ; Pan XL; Song L
J Int Med Res; 2013 Aug; 41(4):1027-36. PubMed ID: 23816930
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus does not have a causal role in colorectal carcinogenesis.
Lorenzon L; Mazzetta F; Pilozzi E; Uggeri G; Torrisi MR; Ferri M; Ziparo V; French D
World J Gastroenterol; 2015 Jan; 21(1):342-50. PubMed ID: 25574110
[TBL] [Abstract][Full Text] [Related]
34. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
Reuschenbach M; Huebbers CU; Prigge ES; Bermejo JL; Kalteis MS; Preuss SF; Seuthe IM; Kolligs J; Speel EJ; Olthof N; Kremer B; Wagner S; Klussmann JP; Vinokurova S; von Knebel Doeberitz M
Cancer; 2015 Jun; 121(12):1966-76. PubMed ID: 25731880
[TBL] [Abstract][Full Text] [Related]
35. Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes.
Scarpini CG; Groves IJ; Pett MR; Ward D; Coleman N
J Pathol; 2014 Jul; 233(3):281-93. PubMed ID: 24752734
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.
Yeung CL; Tsang TY; Yau PL; Kwok TT
Oncotarget; 2017 Feb; 8(7):12158-12173. PubMed ID: 28077801
[TBL] [Abstract][Full Text] [Related]
37. Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.
Tiwari D; Ray Das C; Sultana R; Kakoti S; Aasif Khan M; Dongre A; Husain SA; Bose PD; Bose S
J Cell Biochem; 2020 Apr; 121(4):2782-2791. PubMed ID: 31692038
[TBL] [Abstract][Full Text] [Related]
38. CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18.
Rosendo-Chalma P; Antonio-Vejar V; Bigoni-Ordóñez GD; Patiño-Morales CC; Cano-García A; García-Carrancá A
Int J Oncol; 2020 Jul; 57(1):301-313. PubMed ID: 32319591
[TBL] [Abstract][Full Text] [Related]
39. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
40. Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03.
Bhattacharya P; Sengupta S
Tissue Antigens; 2007 Oct; 70(4):283-93. PubMed ID: 17767549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
